Laguna Pharmacueticals' Series B - II Round

Laguna Pharmacueticals raised a round of funding on July 30, 2015.

Laguna Pharmaceuticals, formerly known as ChanRx, is a biopharmaceutical company advancing vanoxerine for treatment of atrial fibrillation and atrial flutter.…

Articles about Laguna Pharmacueticals' Series B - II Round: